Please provide your email address to receive an email when new articles are posted on . Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — A percutaneous femoropopliteal bypass system appears to be feasible, according to interim results of ...
MILPITAS, Calif.--(BUSINESS WIRE)--Silicon Valley-based medical device company PQ Bypass announced today the 100th patient in the DETOUR2 Clinical Trial, which evaluates the safety and effectiveness ...
One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...